ASCO 2023

Home Tag

cristina saurez web 3

CONTACT-03: underscoring the need to identify new treatment strategies in metastatic renal cancer after disease progression with prior immunotherapy

Led by Toni K. Choueiri at the Dana Farber Cancer Institute, Harvard Medical School in Boston (USA), the CONTACT-03 study…

Joan Carles- web

ASCO 2023: novel treatment combination shows promise as first-line treatment in patients with metastatic castration-resistant prostate cancer

New additional data from the phase 3 TALAPRO-2 study, presented today at the 2023 Annual Meeting of the American Society of…

Cesar Serrano web

Dissecting GIST’s molecular landscape in the largest series of real-world patients reported to date

Led by VHIO’s César Serrano, alongside first author Jonathan C. Trent at the Sylvester Comprehensive Cancer Center in Miami, an…

Ana Oakin web

The promise of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer

Presented today by VHIO’s Ana Oaknin at the 2023 ASCO Annual Meeting, 2-6 June (Chicago, IL), updated dose expansion data…